Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Ear, Nose, and Throat Diseases

Nervous System Diseases

Symptoms and General Pathology

Ganglion Cysts

Hearing Loss

Deafness

Vertigo

Dizziness

Synovial Cyst

Meniere Disease

Cysts

Mucinoses

Connective Tissue Diseases

Vestibular Diseases

Labyrinth Diseases

Labyrinthitis

Ear Diseases

Otorhinolaryngologic Diseases

Neurologic Manifestations

Edema

Endolymphatic Hydrops

Micronutrients

Vasodilator Agents

Lipid Regulating Agents

All Drugs and Chemicals

Antiemetics

Gastrointestinal Agents

Hematinics

Vitamins

Niacin

Nicotinic Acids

Tocopherols

Vitamin E

Tocotrienols

alpha-Tocopherol

Diphenidol

Niacinamide

Antioxidants

Protective Agents

Trace Elements

Hypolipidemic Agents

Antimetabolites

Folic Acid

Vitamin B Complex

Nicotinic Acid

Vitamin B3

Tocopherol

Tocotrienol

Nicotinamide

Folate

Vitamin B9

treated with oral medications: 0.25mg of erispan@ (fludiazine) , 25mg cephadol@ (diphenidol), and 200mg kentons@ (tocopherol nicotinate).

stellate ganglion block

0.25mg of erispan@ (fludiazine), p.o. one dose only.

0.25mg, fludiazine

25mg cephadol@ (diphenidol) p.o. one dose only.

25mg cephadol@ (diphenidol)

200mg kentons@ (tocopherol nicotinate) p.o. one dose only.

200mg kentons@ (tocopherol nicotinate).

Yung-Song Lin, M.D.

Stellate ganglion block (SGB) has been the alternative treatment of Meniere's disease for years. However, objective evidence of the effect of SGB was still lack. The investigators conducted a randomized controlled study to examine the immediate effects of SGB in SP/AP of electrocochleography (ECoG).

Ten patients were randomly assigned to receive stellate ganglion block. These ten patients made up the experimental group. Another ten patients in the control group were assigned to receiving one dosage of oral medications: 0.25mg of erispan@ (fludiazine) , 25mg cephadol@ (diphenidol), and 200mg kentons@ (tocopherol nicotinate).

Effect of Stellate Ganglion Block on Meniere's Disease

SP/AP of ECoG was recorded 2 hours after SGB. to be compared with the SP/AP of ECoG recorded before treatment

SP/AP recorded at 4 hours after SGB was compared with that of pretreatment with SGB

SP/AP recorded at 4 hours after SGB was compared with the SP/AP recorded before SGB

scores of verbal scale for vertigo recorded at 6 hours after SGB was compared to the scores recorded before SGB

Chi Mei Medical Hospital

Chairman of department of Otolaryngology

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Effect of Stellate Ganglion Block on Meniere's Disease	NCT01574313	Vertigo Meniere Disease	stellate gangli... 0.25mg, fludiaz... 25mg cephadol@ ... 200mg kentons@ ...	30 Years - 65 Years	Chi Mei Medical Hospital
Effect of Stellate Ganglion Block on Meniere's Disease	NCT01574313	Vertigo Meniere Disease	stellate gangli... 0.25mg, fludiaz... 25mg cephadol@ ... 200mg kentons@ ...	30 Years - 65 Years	Chi Mei Medical Hospital

Spots Global Cancer Trial Database for hearing impairment.